A

Artielle ImmunoTherapeutics

10 employees

Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.

Basic info

Industry

wellness and fitness services

Sectors

Biotechnology
Therapeutics
Biopharma

Date founded

2004

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

A

Artielle ImmunoTherapeutics raised $11M on June 23, 2004

Investors: Pelion Venture Partners and Sanderling Ventures

FAQ